Trials / Completed
CompletedNCT06873438
The Effect of Probiotics on the Improvement of Intestinal and Immune Function
A Study on the Safety and Effectiveness of Lactobacillus Delbrueckii Subsp. Bulgaricus LB42 in Improving Intestinal and Immune Functions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Wecare Probiotics Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the effectiveness and safety of Lactobacillus delbrueckii subsp. bulgaricus LB42 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic group | The experimental phase of this study will last 8 weeks and each subject will receive 3 follow-up visits (week 0, week 4, week 8). |
| DIETARY_SUPPLEMENT | Placebo group | The experimental phase of this study will last 8 weeks and each subject will receive 3 follow-up visits (week 0, week 4, week 8). |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2025-05-25
- Completion
- 2025-08-15
- First posted
- 2025-03-12
- Last updated
- 2025-10-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06873438. Inclusion in this directory is not an endorsement.